EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps

Efrat Hamami iD, Wenwen Huo, Katherine Neal, Isabelle Neisewander, Shivangi, Joel S Freundlich, Edward Geisinger iD, Ralph R Isberg iD

mBio · 2026

DOI: 10.1128/mbio.00902-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Efrat Hamami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Membrane Transport Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated expression of resistance-nodulation-cell division (RND) drug transporters is commonly observed in clinical isolates of Acinetobacter baumannii , a nosocomial pathogen associated with multidrug-resistant infections. We describe here a CRISPRi platform directed toward identifying essential gene hypomorphs that preferentially change resistance to the fluoroquinolone antibiotic ciprofloxacin in RND pump overproducers. An sgRNA library, including single and double nucleotide mutations directed against essential genes of A. baumannii was constructed and introduced into multiple strain backgrounds, allowing strain-specific, titratable knockdown efficiencies to be analyzed. Other than NusG depletions, few candidates showed lowered fitness in the absence of drug treatment, specifically in strains overexpressing the RND efflux pumps AdeAB, AdeIJK, or AdeFGH. In the presence of ciprofloxacin, the hypomorphs that caused hypersensitivity were predicted to result in outer membrane dysfunction, with the AdeFGH overproducer appearing particularly sensitive to such disruptions. Most notably, depletion of the predicted monovalent cation-proton antiporter component PhaF compromised efflux pump function, as it resulted in increased ciprofloxacin accumulation in strains overproducing AdeFGH and disrupted cytosolic pH. On the other hand, depletions of translation-associated proteins and components of the proton-pumping ATP synthase conferred fitness benefits in the presence of the drug in at least two pump-overproducing strains. Therefore, pump overproduction exacerbated stress caused by defective outer membrane integrity, while the activity of at least one efflux pump overproducer required the function of an antiporter that maintains cytosolic pH homeostasis. IMPORTANCE Acinetobacter baumannii clinical isolates are increasingly multidrug-resistant, leaving patients with few effective treatment options. Many of these isolates are fluoroquinolone resistant due to drug target mutations in the two major type II topoisomerases, as well as mutations that activate resistance-nodulation-cell division efflux pump expression. This work identifies essential gene products that support the fitness of efflux pump hyperexpressers during treatment with the fluoroquinolone antibiotic ciprofloxacin, most of which are involved in OM biogenesis. These findings suggest new strategies for combination therapy with currently available fluoroquinolones to sensitize and combat high-level resistant strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialMembrane Transport ProteinsBacterial Outer Membrane ProteinsBacterial Outer MembraneCiprofloxacinMicrobial Sensitivity TestsGenes, EssentialBacterial Proteins

Stichwörter der Autor:innen

Acinetobacter baumanniiCRISPRiRND efflux pumpsantimicrobial combinationsmultidrug resistance

Substanzen

Anti-Bacterial AgentsMembrane Transport ProteinsCiprofloxacinBacterial Outer Membrane ProteinsBacterial Proteins

Autor:innen und Institutionen

  • Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Department of Biochemistry, Curry College, Milton, Massachusetts, USA.
  • Department of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, New Jersey, USA.
  • Division of Infectious Disease, Department of Medicine and the Ruy V. Lourenco Center for the Study of Emerging and Re-Emerging Pathogens, Rutgers University-New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Biology, Northeastern University, Boston, Massachusetts, USA.

ORCID-Profile: Efrat Hamami, Edward Geisinger, Ralph R Isberg

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Hamami, E., Huo, W., Neal, K., Neisewander, I., Shivangi, Freundlich, J. S., Geisinger, E., & Isberg, R. R. (2026). Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps. mBio. https://doi.org/10.1128/mbio.00902-26

Vancouver

Hamami E, Huo W, Neal K, Neisewander I, Shivangi, Freundlich JS, et al. Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps. mBio. 2026. doi:10.1128/mbio.00902-26

BibTeX
@article{Hamami2026,
  author = {Hamami, Efrat and Huo, Wenwen and Neal, Katherine and Neisewander, Isabelle and Shivangi and Freundlich, Joel S and Geisinger, Edward and Isberg, Ralph R},
  title = {Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps},
  journal = {mBio},
  year = {2026},
  doi = {10.1128/mbio.00902-26}
}
Kostenlos starten →